FTO and obesity due to melanocortin 4 receptor deficiency: Clinical studies indicate that insulin sensitivity [469] and engagement in physical activity [470, 471, 472, 473, 474, 475, 476] have been observed to lessen the impact of the FTO genotype on obesity‐related characteristics.